Short Interest in CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) Grows By 10.3%

CERo Therapeutics Holdings, Inc. (NASDAQ:CEROW) was the target of a significant growth in short interest during the month of December. As of December 31st, there was short interest totalling 20,300 shares, a growth of 10.3% from the December 15th total of 18,400 shares. Based on an average trading volume of 163,500 shares, the short-interest ratio is currently 0.1 days.

CERo Therapeutics Stock Performance

Shares of CEROW stock traded up $0.00 during mid-day trading on Friday, hitting $0.02. The company’s stock had a trading volume of 37,939 shares, compared to its average volume of 290,885. CERo Therapeutics has a 52 week low of $0.00 and a 52 week high of $0.25. The company’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.01.

About CERo Therapeutics

CERo Therapeutics Holdings, Inc, an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies. The company was incorporated in 2021 and is based in South San Francisco, California.